Combining hepatitis B core ‐related and surface antigens at end of nucleos(t)ide analogue treatment to predict off‐therapy relapse risk

ConclusionsSerum HBcrAg and HBsAg levels were independent predictors of off ‐NA relapse and can be factored into a risk score to guide treatment cessation in patients with CHB.

Source: Alimentary Pharmacology and Therapeutics - November 19, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Chun Hsu, Mindie H. Nguyen, Lein‐Ray Mo, Ming‐Shiang Wu, Tzeng‐Huey Yang, Chieh‐Chang Chen, Cheng‐Hao Tseng, Chi‐Ming Tai, Chun‐Ying Wu, Jaw‐Town Lin, Yasuhito Tanaka, Chi‐Yang Chang Tags: ORIGINAL ARTICLE Source Type: research